[Clinical trial of pancuronium bromide].
D000731:Androstanes / Q000494:pharmacology*; D001965:Bromides / Q000494:pharmacology; D004558:Electric Stimulation; D005071:Evoked Potentials; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D009388:Neostigmine / Q000494:pharmacology; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology*; D014403:Tubocurarine / Q000037:antagonists & inhibitors / Q000494:pharmacology
D000731:Androstanes; D001965:Bromides; D003473:Neuromuscular Nondepolarizing Agents; D010880:Piperidines; D009388:Neostigmine; D014403:Tubocurarine